Venture Capitalist and Partner Mr. William Werkmeister, also known as Bill, is a Founding Partner of the International Cancer Impact Fund, and in charge of the fund operations, organization, and capital raising efforts. He is a serial social venture capitalist and social entrepreneur. In addition to ICIF, Bill manages a…...
Robin Wang
Opera Singer, Angel Investor and Philanthropist Robin is a mezzo-soprano singer whose tone is described by the industry as “crystal-like” with the experience as in international singer. Her repertoire ranges from modern, classical, oriental and western styles. She has held concerts at the Kennedy Center, Lincoln Center, the United States,…...
Cristina Campabadal
President and CEO, CCS Finanzas Cristina Campabadal is the founding President and CEO of the CCS Finanzas, a financial services firm, helping high net worth Latam and Iberian families with their investments and wealth since 2017. She currently serves as columnist at Yahoo Finance USA-Latin America-Spain writing about the financial…...
Charlie Weatherspoon
Chief Executive Officer, Integral CFO Services LLC Charlie Weatherspoon co-founded The AIM HI Translational Research Fund (AIM-HI) and serves as the chairman of the board. He is the Chief Executive Officer and Co-Founder of Integral CFO Services LLC. Integral CFO Services provides resource networking, business consulting and various management related…...
Franklin Salisbury, Jr.
NFCR CEO Emeritus Franklin Salisbury, Jr. has a background in economics, law and religion. Trained in resource economics at Yale, he has spent his career fostering innovative collaborations with experts in different fields so they might work together to address and solve acute social, healthcare and environmental issues. Bachelors of…...
Frederick W. Alt, Ph.D.
Charles A. Janeway Professor of Pediatrics & Professor of Genetics, Harvard Medical School Investigator, Howard Hughes Medical Institute, Boston Children’s Hospital Dr. Frederick Alt received his Ph.D. in Biology from Stanford University in 1977 where he worked with Robert Schimke. He moved to MIT for postdoctoral work with David Baltimore,…...
Peter K. Vogt, Ph.D.
Professor of Molecular Medicine, Scripps Research Institute Dr. Peter Vogt is a molecular biologist, virologist and geneticist. His research focuses on retroviruses and viral and cellular oncogenes. Dr. Vogt received his undergraduate education in biology at the University of Würzburg and in 1959 was awarded his Ph.D. at the University…...
Kanaga Sabapathy, Ph.D.
Head, Division of Cellular and Molecular Research, National Cancer Center Singapore Dr. Sabapathy obtained his Ph.D. in Molecular and Cellular Immunology from the Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore, in 1995. After a post-doctoral stint at the Institute of Molecular Pathology in Vienna, Austria, he moved to…...
Brian Leyland-Jones, M.B., B.S., Ph.D.
Chief Medical Officer, AIM-HI Accelerator Fund Brian Leyland-Jones, BSc (Ist class Hons), MB BS, PhD, FRACP, FRCPC is the Chief Medical Officer of AIM-HI Accelerator Fund and the N OF 1 Mission, CSO of The Darwin Foundation, collectively devoted to the implementation of prevention and cure of malignancy globally. He…...
